Hypothalamic & Pituitary Hormones Flashcards
Effects of GH is primarily mediated by regulating the production of ______ in peripheral tissues.
Insulin-like Growth Factor 1
(IGF-1)
Recombinant form of human GH.
Somatropin.
-acts through GH receptors to increase production of IGH-I
GH/Somatropin in Children.
- Genetic diseases associated with short stature:
- Turner syndrome.
- Noonan syndrome.
- Prader-Willi syndrome. - To improve growth in children with failure to thrive due to chronic renal failure or the small-for-gestational-age condition.
Controversial use of GH/Somatotropin.
Idiopathic short stature who are not GH deficient.
-Great cost.
-Risk of toxicity.
Result: 1.5-3 inches average increase in final adult height.
GH/Somatotropin in Adults.
- Treatment of AIDS-associated wasting.
- GH deficiency.
- Improve GIT function in patients who have undergone intestinal resection and have subsequently developed a malabsorption syndrome.
- Increase in muscle mass for athletes.
- Recombinant bovine GH is used to increase milk production in cattle.
Antiaging programs use GH; sideeffects.
Analogs of GH and IGF-1 shorten lifespan.
Rare, serious adverse effects of GH in children.
- Pseudotumor cerebri.
- Slipped capital femoral epiphysis.
- Progression of scoliosis.
- Edema.
- Hyperglycemia.
Adverse effects of GH in adults.
- Peripheral edema.
- Myalgia.
- Arthralgia.
Recombinant human IGF-1.
Mecasermin.
______ is administered parenterally to children with IGF-1 deficiency.
Mecasermin
Toxicity of Mecasermin.
Hypoglycemia, intracranial hypertension, increased liver enzymes.
rhIGFBP-3.
In some countries, children are treated with Mecasermin Rinfabate, a combination of recombinant human IGF-1 and human insulin-like growth factor-binding protein-3.
Mecasermin rinfabate increases the half-life of IGF-1.
Growth hormone secreting pituitary adenomas.
Adults - Acromegaly.
Children and Adolescents - Gigantism
Somatostatin.
A 14 amino acid peptide.
Inhibits release of GH, Glucagon, Insulin, Gastrin.
Ocreotide and Lanreotide.
-Long-acting synthetic analogs of somatostatin.
Used to treat:
-Acromegaly
-Carcinoid
-Gastrinoma
-glucagonoma
-other endocrine tumors
Regular Octreotide.
- Administered subcutaneously.
- 2-4 times a day.
- A somatostatin analogue having high potency and long duration of action.
- It is preferred over somatostatin for all the indications.
- Also inhibits TSH secretion and is the treatment of choice for TSH-secreting adenoma in patients who are not the candidates of surgery.
Slow-release intramuscular formulation of ocreotide or lanreotide.
Administered every 4 weeks for long-term therapy.
Side effects of Ocreotide and Lantreotide.
- GIT disturbances
- Gallstones
- Cardiac conduction abnormalities
Hypothalamus secretes GHRH.
Increases GH release.
Somatostatin.
Inhibits GH release.